These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 16112616)

  • 1. Diminished neo-antigen response to keyhole limpet hemocyanin (KLH) vaccines in patients after treatment with chemotherapy or hematopoietic cell transplantation.
    Miller JS; Curtsinger J; Berthold M; Malvey K; Bliss RL; Le CT; Fautsch SK; Dudek AZ; Blazar BR; Panoskaltsis-Mortari A
    Clin Immunol; 2005 Nov; 117(2):144-51. PubMed ID: 16112616
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Potential of dendritic-cell immunotherapy for relapse after allogeneic hematopoietic stem cell transplantation, shown by WT1 peptide- and keyhole-limpet-hemocyanin-pulsed, donor-derived dendritic-cell vaccine for acute myeloid leukemia.
    Kitawaki T; Kadowaki N; Kondo T; Ishikawa T; Ichinohe T; Teramukai S; Fukushima M; Kasai Y; Maekawa T; Uchiyama T
    Am J Hematol; 2008 Apr; 83(4):315-7. PubMed ID: 18081032
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Detection of humoral response in patients with glioblastoma receiving EGFRvIII-KLH vaccines.
    Schmittling RJ; Archer GE; Mitchell DA; Heimberger A; Pegram C; Herndon JE; Friedman HS; Bigner DD; Sampson JH
    J Immunol Methods; 2008 Nov; 339(1):74-81. PubMed ID: 18775433
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antibody response to keyhole limpet hemocyanin (KLH) treatment in patients with superficial bladder carcinoma.
    Jurincic-Winkler CD; von der Kammer H; Beuth J; Scheit KH; Klippel KF
    Anticancer Res; 1996; 16(4A):2105-10. PubMed ID: 8712751
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical outcome of breast and ovarian cancer patients treated with high-dose chemotherapy, autologous stem cell rescue and THERATOPE STn-KLH cancer vaccine.
    Holmberg LA; Oparin DV; Gooley T; Lilleby K; Bensinger W; Reddish MA; MacLean GD; Longenecker BM; Sandmaier BM
    Bone Marrow Transplant; 2000 Jun; 25(12):1233-41. PubMed ID: 10871727
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Consistent antibody response against ganglioside GD2 induced in patients with melanoma by a GD2 lactone-keyhole limpet hemocyanin conjugate vaccine plus immunological adjuvant QS-21.
    Ragupathi G; Livingston PO; Hood C; Gathuru J; Krown SE; Chapman PB; Wolchok JD; Williams LJ; Oldfield RC; Hwu WJ
    Clin Cancer Res; 2003 Nov; 9(14):5214-20. PubMed ID: 14614001
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunogenicity of dendritic cells pulsed with CEA peptide or transfected with CEA mRNA for vaccination of colorectal cancer patients.
    Lesterhuis WJ; De Vries IJ; Schreibelt G; Schuurhuis DH; Aarntzen EH; De Boer A; Scharenborg NM; Van De Rakt M; Hesselink EJ; Figdor CG; Adema GJ; Punt CJ
    Anticancer Res; 2010 Dec; 30(12):5091-7. PubMed ID: 21187495
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vaccination of high-risk breast cancer patients with mucin-1 (MUC1) keyhole limpet hemocyanin conjugate plus QS-21.
    Gilewski T; Adluri S; Ragupathi G; Zhang S; Yao TJ; Panageas K; Moynahan M; Houghton A; Norton L; Livingston PO
    Clin Cancer Res; 2000 May; 6(5):1693-701. PubMed ID: 10815887
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tumor cell lysate-pulsed human dendritic cells induce a T-cell response against pancreatic carcinoma cells: an in vitro model for the assessment of tumor vaccines.
    Schnurr M; Galambos P; Scholz C; Then F; Dauer M; Endres S; Eigler A
    Cancer Res; 2001 Sep; 61(17):6445-50. PubMed ID: 11522639
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Modulation of systemic antigen-specific immune responses by oral antigen in humans.
    Kapp K; Maul J; Hostmann A; Mundt P; Preiss JC; Wenzel A; Thiel A; Zeitz M; Ullrich R; Duchmann R
    Eur J Immunol; 2010 Nov; 40(11):3128-37. PubMed ID: 20957752
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Route of administration modulates the induction of dendritic cell vaccine-induced antigen-specific T cells in advanced melanoma patients.
    Lesterhuis WJ; de Vries IJ; Schreibelt G; Lambeck AJ; Aarntzen EH; Jacobs JF; Scharenborg NM; van de Rakt MW; de Boer AJ; Croockewit S; van Rossum MM; Mus R; Oyen WJ; Boerman OC; Lucas S; Adema GJ; Punt CJ; Figdor CG
    Clin Cancer Res; 2011 Sep; 17(17):5725-35. PubMed ID: 21771874
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Idiotype vaccination of multiple myeloma patients using monocyte-derived dendritic cells.
    Reichardt VL; Milazzo C; Brugger W; Einsele H; Kanz L; Brossart P
    Haematologica; 2003 Oct; 88(10):1139-49. PubMed ID: 14555310
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Preexisting antigen-specific immune responses are modulated by oral KLH feeding in humans.
    Hostmann A; Meyer T; Maul J; Preiss J; Boortz B; Thiel A; Duchmann R; Ullrich R
    Eur J Immunol; 2015 Jul; 45(7):1991-6. PubMed ID: 25847325
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A phase I trial of tumor lysate-pulsed dendritic cells in the treatment of advanced cancer.
    Chang AE; Redman BG; Whitfield JR; Nickoloff BJ; Braun TM; Lee PP; Geiger JD; Mulé JJ
    Clin Cancer Res; 2002 Apr; 8(4):1021-32. PubMed ID: 11948109
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunogenicity of a fucosyl-GM1-keyhole limpet hemocyanin conjugate vaccine in patients with small cell lung cancer.
    Dickler MN; Ragupathi G; Liu NX; Musselli C; Martino DJ; Miller VA; Kris MG; Brezicka FT; Livingston PO; Grant SC
    Clin Cancer Res; 1999 Oct; 5(10):2773-9. PubMed ID: 10537341
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Epidermal growth factor receptor VIII peptide vaccination is efficacious against established intracerebral tumors.
    Heimberger AB; Crotty LE; Archer GE; Hess KR; Wikstrand CJ; Friedman AH; Friedman HS; Bigner DD; Sampson JH
    Clin Cancer Res; 2003 Sep; 9(11):4247-54. PubMed ID: 14519652
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Induction of cellular immune responses in patients with stage-I multiple myeloma after vaccination with autologous idiotype-pulsed dendritic cells.
    Röllig C; Schmidt C; Bornhäuser M; Ehninger G; Schmitz M; Auffermann-Gretzinger S
    J Immunother; 2011 Jan; 34(1):100-6. PubMed ID: 21150718
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A cancer vaccine based on fluorine-modified sialyl-Tn induces robust immune responses in a murine model.
    Song C; Zheng XJ; Liu CC; Zhou Y; Ye XS
    Oncotarget; 2017 Jul; 8(29):47330-47343. PubMed ID: 28537884
    [TBL] [Abstract][Full Text] [Related]  

  • 19. T helper 2 biased de novo immune response to Keyhole Limpet Hemocyanin in humans.
    Spazierer D; Skvara H; Dawid M; Fallahi N; Gruber K; Rose K; Lloyd P; Heuerding S; Stingl G; Jung T
    Clin Exp Allergy; 2009 Jul; 39(7):999-1008. PubMed ID: 19236409
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vaccination of patients with small-cell lung cancer with synthetic fucosyl GM-1 conjugated to keyhole limpet hemocyanin.
    Krug LM; Ragupathi G; Hood C; Kris MG; Miller VA; Allen JR; Keding SJ; Danishefsky SJ; Gomez J; Tyson L; Pizzo B; Baez V; Livingston PO
    Clin Cancer Res; 2004 Sep; 10(18 Pt 1):6094-100. PubMed ID: 15447995
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.